Praxis Precision Medicines
Presence
Praxis Precision Medicines is a company listed under the stock ticker PRAX (US).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Praxis Precision Medicines
- Marcio Souza, President and Chief Executive Officer
- Jill Desimone, Director
- Merit Cudkowicz, Director
Create your alert
to follow the executive moves at Praxis Precision Medicines.
Biotechnology
Praxis Precision Medicines has 2,274 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
Popular contacts in Biotechnology
News
Press releases by Praxis Precision Medicines
- Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference - Praxis Precision Medicines, Inc.
- Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference - Praxis Precision Medicines, Inc.
- Praxis Precision Medicines Reports Negative Results from PRAX-114 Phase 2/3 Monotherapy Aria Study in Patients with Major Depressive Disorder - Praxis Precision Medicines, Inc.
- Praxis Precision Medicines Reports Negative Results from PRAX-114 Phase 2/3 Monotherapy Aria Study in Patients with Major Depressive Disorder - Praxis Precision Medicines, Inc.
- Praxis Precision Medicines Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone - Praxis Precision Medicines, Inc.
- Praxis Precision Medicines Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone - Praxis Precision Medicines, Inc.
- Press Releases | Praxis Precision Medicines, Inc.
- Praxis Precision Medicines to Present at Upcoming Investor Conferences - Praxis Precision Medicines, Inc.
- Praxis Precision Medicines to Present at Upcoming Investor Conferences - Praxis Precision Medicines, Inc.
- Praxis Precision Medicines Reports Positive Topline Results from PRAX-944 Phase 2a Study in Essential Tremor Patients - Praxis Precision Medicines, Inc.
- View more press releases Close
Social media about Praxis Precision Medicines
- Praxis Precision Medicines on Wikipedia, Google News & Yahoo Finance
- Praxis Precision Medicines on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Marcio Souza 
Call Praxis Precision Medicines at +1 617...
